What to expect in the Organon & Co. interview process

Based on publicly available sources, Organon & Co. is a New Jersey-headquartered pharmaceutical company spun off from Merck & Co. in 2020, focusing on women’s health, biosimilars, and established medicines. The company employs approximately 9,538 people worldwide as of March 2026, reflecting a 5.2% workforce headcount decline since 2023. Despite this contraction, hiring activity shows an uptick, with 186 active job postings recorded in 2026—a 71.5% increase from 2025—alongside flexible working options in areas like medical sales.

Employee sentiment presents a mixed internal picture. The company holds an above-average employee rating of 76/100, indicating general satisfaction with workplace culture, compensation, and management, though it trails several industry peers. Meanwhile, employee business outlook sits at a moderate 47% and has softened by 6% over a three-month period, pointing to a workforce roughly split on the company's direction.

Organon utilizes tools like Perceptyx for workforce analytics and employee listening initiatives to shape remote work, well-being, and internal feedback mechanisms. Initiatives such as the Families@Work employee resource group and regional recognitions, like Organon ANZ’s certification as a Family Inclusive Workplace, highlight an emphasis on family-friendly policies and a "people first" cultural framework established following its formation.